<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01772888</url>
  </required_header>
  <id_info>
    <org_study_id>12-103</org_study_id>
    <nct_id>NCT01772888</nct_id>
  </id_info>
  <brief_title>Chewing Efficiency Measured by a Two Colour Chewing Gum Test in Amyotrophic Lateral Sclerosis (ALS) Patients?</brief_title>
  <official_title>Chewing Efficiency Measured by a Two Colour Chewing Gum Test: a Marker of Insufficient Nutritional Intakes and Percutaneous Gastrostomy (PEG) Necessity in ALS Patients?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study aims: The primary aim is to determine whether chewing efficiency, determined by a&#xD;
      two-colour mixing ability test, and maximum bite and lip force decrease in ALS patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study center: University Hospitals of Geneva Study type: Cohort study with matched controls&#xD;
      Study population: 25 ALS patients included in the multidisciplinary cohort study of the&#xD;
      University Hospital Geneva between October 2012 and October 2014 and followed for 3 years&#xD;
      maximum and 25 controls, matched for age, sex and dental status.&#xD;
&#xD;
      Study duration: Inclusion from October 2012 to October 2016. Follow-up for 3 years.&#xD;
&#xD;
      Study hypothesis: Chewing efficiency, maximum bite and lip force decrease with time in ALS&#xD;
      patients and may be a marker of texture adaptation and PEG necessity.&#xD;
&#xD;
      Study aims: The primary aim is to determine whether chewing efficiency, determined by a&#xD;
      two-colour mixing ability test, and maximum bite and lip force decrease in ALS patients.&#xD;
&#xD;
      The secondary aims are to determine, in ALS patients, whether:&#xD;
&#xD;
        -  Maximum bite and lip force decrease.&#xD;
&#xD;
        -  Chewing efficiency, maximum bite and lip force decrease more in ALS patients with bulbar&#xD;
           than with spinal onset.&#xD;
&#xD;
        -  Chewing efficiency and bite force correlate with energy intakes, nasofibroscopic&#xD;
           assessment, and a validated swallowing questionnaire.&#xD;
&#xD;
        -  Saliva volume increases with time and progression of disease and influences masticatory&#xD;
           efficiency.&#xD;
&#xD;
        -  Saliva volume is associated with nasofibroscopy assessment.&#xD;
&#xD;
      Methods : Every three months, we will perform:&#xD;
&#xD;
        -  As part of the ongoing cohort study (already accepted by the Ethical Committee)&#xD;
           calculation of energy intakes through a 24h recall, nasofibroscopy, swallowing&#xD;
           questionnaire and score of disease severity.&#xD;
&#xD;
        -  As part of this study: assessment of dental status at first visit, chewing efficiency&#xD;
           test by a with a colour mixing ability test, maximum voluntary bite and lip force,&#xD;
           saliva volume and calculation of a 3-day dietary recall instead of a 24h recall.&#xD;
&#xD;
      Statistics: Evolutions with time and between groups, of chewing efficiency, bite and lip&#xD;
      force will be assessed by repeated measures ANOVA. Correlations between two continuous&#xD;
      variables will be examined by Spearman's correlation coefficients at the different time&#xD;
      points. Correlations between a continuous variable and a binary variable (nasofibroscopic&#xD;
      assessment) will be explored by logistic regression with mixed effect model.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">July 2019</completion_date>
  <primary_completion_date type="Actual">July 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>- Chewing efficiency</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lip force</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bite force</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calorie and protein intakes</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Saliva volume</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">25</enrollment>
  <condition>Amyotrophic Lateral Sclerosis 11</condition>
  <arm_group>
    <arm_group_label>Patients with ALS</arm_group_label>
    <description>All subjects aged &gt; 18 years, diagnosed with an ALS and included in the multidisciplinary follow-up of the HUG at time of diagnosis will be considered and included, if possible, at their first visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy age and gender-matched subjects</arm_group_label>
    <description>Controls matched for age and gender and dental status and without a medical history for neurological or otolaryngologic disease (1 control for 1 patient). They will be recruited among hospital staff and patients of the dental school.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        ALS patients participating in the cohort study of the University Hospital Geneva&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ALS patients&#xD;
&#xD;
          -  &gt; 18 years&#xD;
&#xD;
          -  Participation in the cohort study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal of participating in the cohort study&#xD;
&#xD;
          -  Presence of PEG&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurence Genton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Schimmel M, Christou P, Herrmann F, MÃ¼ller F. A two-colour chewing gum test for masticatory efficiency: development of different assessment methods. J Oral Rehabil. 2007 Sep;34(9):671-8.</citation>
    <PMID>17716266</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 17, 2013</study_first_submitted>
  <study_first_submitted_qc>January 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2013</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Genton Graf Laurence</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

